Achilles Therapeutics

Developer of T-cell therapies for cancer

placeLondon, England, United Kingdom calendar_todayFounded 2016 groups118 employees language achillestx.com

Registered entities

Innovation

6 patent families — focus: Human necessities, Physics & computing; filing pace dormant. Cited 48 times.

YearFilings
20181
20191
20204

Investor mix

43 investors on record; lead investors include RA Capital Management, Syncona, Orbimed, Boxer Capital.

Investor typeCountShare
Venture capital1023%
Private equity12%
Other / undisclosed3274%
Coming soon